Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ritter Pharmaceuticals

0.4480
0.0000
Volume:- -
Turnover:- -
Market Cap:20.68M
PE:-1.03
High:0.4480
Open:0.4480
Low:0.4480
Close:0.4480
Loading ...
Mar 31, 2020

Annual Report

Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2020

Correspondence

CORRESP [Cover] - Correspondence
Mar 11, 2020

Major Issues Report

Current report, items 1.01, 3.02, and 9.01
Mar 11, 2020

Business Combinations

Prospectuses and communications, business combinations
Mar 03, 2020

Major Issues Report

Current report, items 8.01 and 9.01
Mar 03, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 21, 2020

Major Issues Report

Current report, items 1.01 and 9.01
Feb 21, 2020

Business Combinations

Prospectuses and communications, business combinations
Feb 14, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Feb 07, 2020

Major Issues Report

Current report, items 3.01 and 8.01
Feb 07, 2020

Business Combinations

Prospectuses and communications, business combinations
Jan 29, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 28, 2020

Beneficial Ownership Change

[Amend] Statement of acquisition of beneficial ownership by individuals
Jan 21, 2020

Major Issues Report

Current report, items 1.01, 8.01, and 9.01
Jan 21, 2020

Business Combinations

Prospectuses and communications, business combinations
Nov 26, 2019

Major Issues Report

Current report, item 3.01
Nov 14, 2019

Major Issues Report

Current report, items 2.02 and 9.01
Nov 14, 2019

Quarterly Report

Quarterly report [Sections 13 or 15(d)]
Nov 07, 2019

Major Issues Report

Current report, items 1.01 and 9.01
Nov 01, 2019

Major Issues Report

Current report, item 3.01